Salesforce.com (CRM) Stock Falls Amid Market Uptick: What Investors Need to Know

11.04.25 23:45 Uhr

Werte in diesem Artikel
Aktien

221,90 EUR -5,00 EUR -2,20%

Indizes

40.212,7 PKT 619,1 PKT 1,56%

16.724,5 PKT 337,1 PKT 2,06%

5.363,4 PKT 95,3 PKT 1,81%

In the latest trading session, Salesforce.com (CRM) closed at $255, marking a -0.05% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 1.81% for the day. Meanwhile, the Dow experienced a rise of 1.56%, and the technology-dominated Nasdaq saw an increase of 2.06%.Shares of the customer-management software developer witnessed a loss of 6.12% over the previous month, beating the performance of the Computer and Technology sector with its loss of 7.27% and the S&P 500's loss of 6.14%.The investment community will be paying close attention to the earnings performance of Salesforce.com in its upcoming release. The company is forecasted to report an EPS of $2.54, showcasing a 4.1% upward movement from the corresponding quarter of the prior year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $9.74 billion, up 6.61% from the year-ago period.For the full year, the Zacks Consensus Estimates project earnings of $11.13 per share and a revenue of $40.78 billion, demonstrating changes of +9.12% and +7.61%, respectively, from the preceding year.Investors should also note any recent changes to analyst estimates for Salesforce.com. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 0.06% higher within the past month. Right now, Salesforce.com possesses a Zacks Rank of #3 (Hold).In terms of valuation, Salesforce.com is currently trading at a Forward P/E ratio of 22.92. Its industry sports an average Forward P/E of 23.2, so one might conclude that Salesforce.com is trading at a discount comparatively.Investors should also note that CRM has a PEG ratio of 1.8 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Computer - Software industry currently had an average PEG ratio of 2.05 as of yesterday's close.The Computer - Software industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 87, positioning it in the top 36% of all 250+ industries.The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow CRM in the coming trading sessions, be sure to utilize Zacks.com.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Salesforce Inc. (CRM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Salesforce und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Salesforce

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Salesforce

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Salesforce

Wer­bung

Analysen zu Salesforce

DatumRatingAnalyst
07.04.2025Salesforce BuyJefferies & Company Inc.
31.03.2025Salesforce BuyJefferies & Company Inc.
07.03.2025Salesforce BuyGoldman Sachs Group Inc.
27.02.2025Salesforce OutperformRBC Capital Markets
27.02.2025Salesforce BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
07.04.2025Salesforce BuyJefferies & Company Inc.
31.03.2025Salesforce BuyJefferies & Company Inc.
07.03.2025Salesforce BuyGoldman Sachs Group Inc.
27.02.2025Salesforce OutperformRBC Capital Markets
27.02.2025Salesforce BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
27.02.2025Salesforce NeutralUBS AG
11.02.2025Salesforce NeutralUBS AG
04.12.2024Salesforce NeutralUBS AG
22.11.2024Salesforce NeutralUBS AG
19.09.2024Salesforce NeutralUBS AG
DatumRatingAnalyst
11.01.2023Salesforce UnderperformBernstein Research
19.06.2020Slack SellGoldman Sachs Group Inc.
19.05.2016Salesforce UnderperformBernstein Research
19.11.2015Salesforce UnderperformBernstein Research
19.11.2015Salesforce verkaufenJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Salesforce nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen